News: immunisation
Research centre funded for global control of two serious infections in young people
University of Adelaide researchers have received $3 million for a new research centre set to determine the most effective immunisation program using one vaccine to protect against both meningococcal disease and gonorrhoea.
Life-saving meningococcal B vaccination program continues indefinitely
South Australia's world-leading Meningococcal B Immunisation Program will continue indefinitely after proving it’s been incredibly effective at preventing the illness in high-risk age groups thanks to research at the University of Adelaide.
[Read more about Life-saving meningococcal B vaccination program continues indefinitely]
Fears children’s immunisation rates will drop
There are fears parents will skip vital vaccinations for their children and that there may be disease outbreaks, because parents are concerned about taking their children to their GP during the COVID-19 pandemic.
[Read more about Fears children’s immunisation rates will drop]
Study results will inform immunisation programs globally
The results of the B Part of It study – the largest meningococcal B herd immunity study ever conducted – are published today in the New England Journal of Medicine.
[Read more about Study results will inform immunisation programs globally]
